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Abstract 
Background: Glycosylation of flavonoids is a promising approach to improve the pharmacokinetic properties and 
biological activities of flavonoids. Recently, many efforts such as enzymatic biocatalysis and the engineered Escheri-
chia coli biotransformation have increased the production of flavonoid glucosides. However, the low yield of flavonoid 
glucosides can not meet the increasing demand for human medical and dietary needs. Saccharomyces cerevisiae is 
a generally regarded as safe (GRAS) organism that has several attractive characteristics as a metabolic engineering 
platform for the production of flavonoid glucosides. However, endogenous glucosidases of S. cerevisiae as a whole-
cell biocatalyst reversibly hydrolyse the glucosidic bond and hinder the biosynthesis of the desired products. In this 
study, a model flavonoid, scutellarein, was used to exploit how to enhance the production of flavonoid glucosides in 
the engineered S. cerevisiae.
Results: To produce flavonoid glucosides, three flavonoid glucosyltransferases (SbGTs) from Scutellaria baicalensis 
Georgi were successfully expressed in E. coli, and their biochemical characterizations were identified. In addition, to 
synthesize the flavonoid glucosides in whole-cell S. cerevisiae, SbGT34 was selected for constructing the engineering 
yeast. Three glucosidase genes (EXG1, SPR1, YIR007W) were knocked out using homologous integration, and the EXG1 
gene was determined to be the decisive gene of S. cerevisiae in the process of hydrolysing flavonoid glucosides. To 
further enhance the potential glycosylation activity of S. cerevisiae, two genes encoding phosphoglucomutase and 
UTP-glucose-1-phosphate uridylyltransferase involved in the synthetic system of uridine diphosphate glucose were 
over-expressed in S. cerevisiae. Consequently, approximately 4.8 g (1.2 g/L) of scutellarein 7-O-glucoside (S7G) was pro-
duced in 4 L of medium after 54 h of incubation in a 10-L fermenter while being supplied with ~3.5 g of scutellarein.
Conclusions: The engineered yeast harbouring SbGT with a deletion of glucosidases produced more flavonoid 
glucosides than strains without a deletion of glucosidases. This platform without glucosidase activity could be used to 
modify a wide range of valued plant secondary metabolites and to explore of their biological functions using whole-
cell S. cerevisiae as a biocatalyst.
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Background
Flavonoids are a group of polyphenolic compounds that 
have various biological activities, such as antioxidant, 
anti-atherosclerosis and anti-tumour [1–3]. In plants, 
flavonoids typically exist in the form of glucosides [4], 
which is beneficial to enhance solubility and stability or 
to change the pharmacokinetic properties [5]. Generally, 
glycosylation, which is the final step in the biosynthesis 
of flavonoid glucosides, is catalysed by glycosyltrans-
ferases (GTs) which transfer sugar moieties from the 
activated donor molecules to specific acceptor molecules 
[6–8]. GTs are divided into 98 families (CAZy database, 
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March 2016) according to their different donors and 
acceptors.
To date, with an increasing demand for flavonoid glu-
cosides, natural plant extracts might not satisfy human 
medical and dietary needs, and chemical synthesis of glu-
cosides requires many protection and deprotection steps, 
which result in non-sustainable and low yield [9]. There-
fore, alternative approaches have been developed for the 
production of flavonoid glucosides, such as purified GTs 
in vitro [10] and the engineered Escherichia coli or Sac-
charomyces cerevisiae in vivo [11, 12]. So far, biocatalytic 
efforts to synthesize of flavonoid glucosides have largely 
focused on enzymatic synthesis and metabolic engineer-
ing of E. coli. The former is typically used to explore novel 
GTs and to characterize their new functions, and the lat-
ter automatically synthesizes sugar donors and directly 
catalyses the glycosylation of the target substrates sup-
plied in the culture medium [10, 13, 14]. However, there 
are very few studies on the engineered yeast for the bio-
synthesis of flavonoid glucosides.
Saccharomyces cerevisiae is an attractive host organ-
ism for the production of flavonoid glucosides. Firstly, it 
is a unicellular eukaryote, which not only has the traits 
of prokaryotes, such as fast growth and advantages for 
culture and genetic manipulation, but also has the typi-
cal characteristics of eukaryotes, which allows for the 
modification of proteins after translation. Therefore, S. 
cerevisiae can be used to express other eukaryotic genes 
to synthesize the desired products. For example, it can 
functionally express Arabidopsis thaliana genes UGD1 
and UXS3 to generate UDP-xylose [15]. In addition, S. 
cerevisiae is a generally regarded as safe (GRAS) organ-
ism that can be used in the production of pharmaceu-
ticals and dietary supplements. However, whole-cell 
bioconversion of naringenin to naringenin 7-O-glucoside 
is impaired by the existence of endogenous glucosidases 
[16]. Additionally, Sabine Schmidt et al. identified several 
efficient glucosidases from yeast using an activity analysis 
of glucosidases in vitro and the corresponding commer-
cial mutant strains [17]. Therefore, these glucosidases, 
which hydrolyse flavonoid glucosides, impede the use of 
S. cerevisiae as a host for the biotechnological production 
of flavonoid glucosides.
In the present work, an engineered S. cerevisiae strain 
was constructed to improve the production of flavonoid 
glucosides. Firstly, three glucosyltransferases (SbGTs) 
were obtained from Scutellaria baicalensis Georgi, 
and the SbGT34 exhibited the greatest activity toward 
scutellarein. Then, the glucosidase genes of S. cerevi-
siae were deleted to remove the hydrolysis of the glu-
coside products. To enhance the supplementation of 
the activated sugar donor UDP-glucose (UDP-Glu), 
two genes (encoding phosphoglucomutase 2 (PGM2) 
and UTP-glucose-1-phosphate uridylyltransferase 1 
(UGP1)) involved in the biosynthesis of UDP-Glu were 
over-expressed in S. cerevisiae. Finally, an engineered 
yeast strain was constructed to enhance the production 
of flavonoid glucosides by combining the expression of 
SbGT34, PGM2, and UGP1 with the deletion of glucosi-
dases. Additionally, to facilitate the biosynthesis of flavo-
noid glucosides, assays on the glucose addition and pH 
were studied in the yeast strain. Bioconversion was fur-
ther improved in a 10-L fermenter and approximately 
1.2 g/L of scutellarein 7-O-glucoside was synthesized in 
4 L of medium supplied with ~3.5 g of scutellarein.
Results
Biochemical characterization of recombinant SbGTs 
protein in vitro
Three SbGT genes [SbGT30, SbGT34 and SbGT56 
(GenBank No. KU712253, KU712254 and KU712255)] 
encoding flavonoid glucosyltransferase with strictly 
regioselectivity of 7-hydroxyl group were identified and 
heterologously expressed in E. coli. The sugar donor 
specificity of these recombinant proteins was analyzed 
using scutellarein as a sugar acceptor and UDP-Glu, 
UDP-glucuronic acid (UDP-GA) and UDP-galactose 
(UDP-Gal) as sugar donors. The results showed that each 
enzyme only selectively accepted UDP-Glu as a sugar 
donor. These three SbGTs catalysed glucosyl transfer to 
scutellarein and produced a single glycosylated product, 
which was clearly identified as scutellarein 7-O-glucoside 
based on the comparison of its LC spectrum, MS and 
MS/MS fragments with authentic sample and the NMR 
spectra (Additional file  1: Supplemental results). The 
relative activity of each enzyme with the same amount of 
enzyme, scutellarein (0.2  mM) and UDP-Glu (0.6  mM) 
was the following: SbGT30, 76.3 %; SbGT34, 100 % and 
SbGT56, 24.6  %. The optimal pH and temperature for 
the SbGT34-mediated transfer of the glucosyl moiety to 
scutellarein were 7.5 and 30  °C, respectively (Additional 
file 1: Figure S2). A kinetic analysis of the SbGTs revealed 
that the Km value of SbGT30 and SbGT56 for scutella-
rein were 155 and 183 %, respectively, of the Km value of 
SbGT34 for scutellarein (Fig. 1). In addition, SbGT34 also 
catalyzed the glycosylation of other flavonoids (data not 
shown). Therefore, SbGT34 was selected to further cata-
lyze the glucosidation of scutellarein in the engineered 
yeast.
Deletion of S. cerevisiae glucosidase genes and its effects 
on the production of scutellarein 7‑O‑glucoside
In S. cerevisiae, the activity of glucosidases, which hydro-
lyse flavonoid glucosides, hinders the use of yeast as a 
host for the biotechnological production of glucosides 
[16, 17]. A flavonoid glucosyltransferase that glucosylated 
Page 3 of 12Wang et al. Microb Cell Fact  (2016) 15:134 
naringenin to naringenin 7-O-glucoside in  vitro from 
Dianthus caryophyllus, which was expressed in S. cer-
evisiae, demonstrated the existence of endogenous glu-
cosidase activity during whole-cell biocatalysis and was 
responsible for a greatly diminished product yield [16, 
17]. In this study, we further confirmed the hydrolytic 
activity of the whole-cell yeast using luteolin 7-O-glu-
coside as a substrate (Additional file  1: Figure S3). The 
results showed that the yeast did hydrolyze β-glucoside, 
which was in agreement with previous studies [16, 17]. 
Therefore, if engineered S. cerevisiae was used to produce 
flavonoid glucosides, a key step in the construction of the 
engineered yeast is the deletion of the glucosidase genes 
of host strain. Thus, in this study, site-directed integra-
tion plasmids were transformed to the W303-1b strain to 
disrupt the glucosidase open reading frames. The result-
ing strains were generated through the targeted DNA 
integration mediated by homologous recombination. The 
knockout workflow is schematically shown in Additional 
file 1: Figure S4.
The integration of plasmids containing the selective 
markers TRP1, ADE2 and URA3, used for the disruption 
of the EXG1, SPR1 and YIR007W genes, respectively, of 
the W303-1b strain resulted in strains being selected on 
auxotrophic solid plates. Furthermore, positively inte-
grated yeast strains were verified using DNA sequenc-
ing of the PCR-amplified fragments corresponding to the 
glucosidase locus from the genomic DNAs of the tested 
transformants. The growth rate of the strains with a dele-
tion of the EXG1 or YIR007W gene was similar to the 
wild-type strain, whereas the strain with the deletion of 
SPR1 gene grew faster than the wild type strain (Fig. 2a).
To identify the glucosidase activity of the knockout 
strains, a degradation assay of flavonoid glucosides with 
whole-cell biocatalysis was performed using luteolin 
7-O-glucoside as a substrate. When the glucoside was 
added to the culture medium with each knockout strain 
and the wild-type strain W303-1b, the remaining rate of 
the substrate in each catalyzing system was varied. The 
degradation of luteolin 7-O-glucoside to luteolin is pre-
sented in Fig.  2b. The luteolin 7-O-glucoside was dra-
matically diminished within 6  h in the wild-type strain 
W303-1b and could not be detected at 24  h. The strain 
W303-1b/EXG1∆ hardly hydrolyzed glucosides within 
Fig. 1 Determination of the kinetic parameters for SbGTs. The apparent Km values were detected using scutellarein as an acceptor and UDP-Glu as a 
donor at 30 °C and a pH of 7.5. The apparent Km values of SbGT30 (a), SbGT34 (b) and SbGT56 (c) were 188, 121 and 222 μM, respectively
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24 h, whereas the strains W303-1b/SPR1∆ and W303-1b/
YIR007W∆ still showed high levels of hydrolytic activity. 
It is worthwhile to note that strain W303-1b/EXG1∆ did 
not hydrolyze glucosides even through it was incubated 
for 96  h during the whole-cell biocatalyst assay (data 
not shown). From these, the deletion of glucosidases 
was determined to be necessary for the glucosylation of 
whole-cell S. cerevisiae [16, 18].
To study strains harbouring SbGT34 to distinguish the 
biotransformation levels of substrates from flavonoids 
to flavonoid glucosides, 0.2 mM scutellarein was fed into 
the biocatalytic reaction systems. The results showed that 
in strain W303-1b/SbGT34, the conversion rate of scutel-
larein into its glucoside was increased slowly within the 
first 20 h, and glucoside achieved the greatest accumula-
tion at 72 h, whereas the production of glucoside in strain 
W303-1b/ES∆/SbGT34 (E and S referred as deletion 
of genes EXG1 and SPR1, respectively) was as approxi-
mately twice the production in strain W303-1b/SbGT34 
at 72 h (Fig. 3) (i.e., the titres of product ranged from 33.4 
to 68.6  mg/L). Therefore, according to the combination 
advantages of strain W303-1b/EXG1∆ that has almost 
no glucosidase activity, and strain W303-1b/SPR1∆ that 
grows fast, a double knockout strain W303-1b/ES∆, which 
had a growth rate similar to strain W303-1b/SPR1∆, was 
used for the further production of flavonoid glucosides.
Bioconversion of scutellarein in vivo
UDP-Glu is a critical endogenous donor in the biosyn-
thesis of flavonoid glucosides in whole-cell S. cerevisiae. 
The biosynthetic pathway of UDP-Glu mainly includes 
two key enzymes: PGM2, which synthesizes glucose-
1-phosphate from glucose-6-phosphate, and UGP1, 
which converts glucose-1-phosphate and UTP into 
UDP-Glu. The whole-cell S. cerevisiae produces endog-
enous UDP-Glu in the cytoplasm that could be used for 
the production of flavonoid glucosides [19–21], but does 
not comprise a GT for the glycosylation of flavonoids. 
To enhance the production of flavonoid glucosides in 
strain W303-1b/ES∆/PU/SbGT34 (P and U referred to 
the over-expression of genes PGM2 and UGP1, respec-
tively), SbGT34 was over-expressed under the control of 
the constitutive promoter along with the up-regulation of 
genes PGM2 and UGP1. The results showed that strain 
W303-1b/ES∆/PU/SbGT34 was more effective (~92  % 
conversion rate) than strain W303-1b/ES∆/SbGT34 
(~75 % conversion rate) (Fig. 3) (i.e., the titres of product 
ranged from 68.6 mg/L to 82.5 mg/L). The analysis of the 
reaction product from the HPLC profiles showed a prod-
uct peak at a retention time of 14.1 min for scutellarein 
7-O-glucoside compared to the standard scutellarein that 
was detected at 19.6 min at a UV absorbance of 280 nm 
(Fig. 4). The HPLC–MS/MS spectra showed an ion peak 
Fig. 2 Hydrolytic activity to luteolin 7-O-glucoside in strains with the 
deletion of glucosidases. a Biomass (OD600). b The remaining rate of 
luteolin 7-O-glucoside in the liquid medium. The values are presented 
as the means, and the error bars show the SD (n = 3)
Fig. 3 Differences in the level of scutellarein 7-O-glucoside produced 
by strains W303-1b/SbGT34, W303-1b/ES∆/SbGT34 and W303-1b/
ES∆/PU/SbGT34 over time. Strains were incubated with 0.2 mM 
scutellarein. The values are presented as the means, and the error bars 
show the SD (n = 3)
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of scutellarein 7-O-glucoside at m/z  =  471 [M  +  Na]+ 
(Additional file  1: Supplemental results). The negative 
experiment was carried out under identical conditions by 
supplementing scutellarein in the strain harbouring the 
empty vector, and no bioconversion of scutellarein was 
observed by analysing the HPLC results.
To explore the substrate inhibition on biotransforma-
tion and cell growth, different concentrations (0.2, 0.4, 
0.6, 0.8, 1.0  mM) of scutellarein were fed into the bio-
catalytic reaction systems (strain W303-1b/ES∆/PU/
SbGT34). The results showed that the bioconversion of 
scutellarein at each concentration gradient into its glu-
coside was rapidly increased in the first 48  h and then 
became static for 72 h, and the inhibition of cell growth 
was elevated with an increase in the concentration of the 
substrate (Fig. 5).
Optimization of the production of flavonoid glucosides 
by regulating the concentration of glucose and the pH 
conditions in the medium
During the fermentation process, glucose as the sole 
carbon source and as the precursor of the sugar donor 
together with the pH of medium is important for prod-
uct synthesis. To further explore the potential of the 
recombinant strain W303-1b/ES∆/PU/SbGT34 for 
the production of scutellarein 7-O-glucoside, four dif-
ferent concentrations (2, 5, 10, 15  %) of glucose were 
Fig. 4 HPLC analysis for scutellarein 7-O-glucoside from the whole-cell biocatalyst assay using strain W303-1b/ES∆/PU/SbGT34. a HPLC profile for 
standard scutellarein. b HPLC profile for the biocatalysis system. c HPLC profile for standard scutellarein 7-O-glucoside
Fig. 5 The influence of different concentrations of scutellarein on 
the cell growth and the conversion rate of scutellarein to scutellarein 
7-O-glucoside. The concentrations of scutellarein were 0.2, 0.4, 0.6, 0.8 
and 1.0 mM. a The conversion rate of scutellarein at different concen-
trations over time. b Biomass (OD600). The values are presented as the 
means, and the error bars show the SD (n = 3)
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supplemented in the synthetic complete (SC) medium 
with 0.6  mM scutellarein as the substrate. As shown in 
Fig. 6a, the conversion rate of scutellarein into its gluco-
side increased with the addition of glucose, and a similar 
transformation rate was observed at glucose concentra-
tions of 10 and 15 % (i.e., the titres of product with the 
two concentrations of glucose was 161.4 and 168.9 mg/L, 
respectively). The supplementation of 10  % glucose 
concentration and 0.6  mM scutellarein acceptor were 
selected to further optimize pH.
Four different pH gradients (4.5, 5.0, 5.5 and 6.0) were 
designed for the biotransformation assay. The concentra-
tion of the phosphate buffer solution was 50  mM, and 
the conversion rate of the substrate was improved by 
approximately 20  % at pH 5.5 compared with the basic 
SC medium (Fig. 6b).
Scale up for the production of scutellarein 7‑O‑glucoside 
using a fermenter
To verify the application of the engineered strain 
W303-1b/ES∆/PU/SbGT34 for the large-scale produc-
tion of scutellarein 7-O-glucoside, optimized concentra-
tions of scutellarein (1.0 mM at 0 h and 2.0 mM at 12 h) 
were added to the 4-L fermentation system in a 10-L 
fermenter. The temperature of fermenter was held at 
30  °C and the pH was maintained at 5.5 by dripping of 
ammonia water during the entire process, and the con-
centration of glucose in the culture was 10 %. The culture 
medium was collected at a given time interval of 6 h and 
was analyzed using HPLC to monitor the conversion of 
substrate to its glucoside.
After 12  h of fermentation, the supplied scutellarein 
was quickly begun to convert to scutellarein 7-O-gluco-
side; thus, additional 2.0  mM of scutellarein was added 
to the reaction system. Additionally, the fermentation 
condition was identical to the initial 12  h. Approximate 
90  % of the supplemented substrate was converted into 
flavonoid glucoside after 54 h of fermentation. The over-
all calculations revealed that the production of scutella-
rein 7-O-glucoside was ~1.2 g/L (i.e., 2.7 mM or 4.8 g/4 
L) from 3.0 mM of supplemented scutellarein (Fig. 7).
Discussion
Dietary flavonoids and especially their glucosides, have 
attracted increasing attention in the past several decades 
for their considerable biological activities [4]. The glyco-
sylation of flavonoids using GTs as the biocatalyst is of 
great general interest due to the synthesis of the desired 
compounds with high stereo- and regio-selectivity under 
mild conditions [4]. In recent studies, the exploration of 
Fig. 6 The influence of different concentrations of glucose and pH 
conditions on the fermentation. a A comparison of the conversion 
rate using 0.6 mM scutellarein in four different concentrations of 
glucose. b A comparison of the conversion rate using 0.6 mM scutel-
larein in four different pH conditions. CK represents the conversion 
rate in the unregulated medium, and the glucose concentration was 
10 %. The values are presented as the means, and the error bars show 
the SD (n = 3)
Fig. 7 The scaled-up production of scutellarein 7-O-glucoside in the 
10-L fermenter. Large-scale bioconversion in the fermenter using 
the SC medium supplemented with 10 % glucose. Scutellarein at 
concentrations of 1 and 2 mM were supplied in the reaction system 
at 0 and 12 h
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GTs mainly focused on enzymology and the semi-synthe-
sis of glucosides using engineered E. coli [4, 13, 22]. The 
in  vitro recombinant enzyme provided a good model to 
study the enzymatic characteristics, and the in  vivo bio-
synthesis of flavonoid glucosides using endogenous sugar 
donors could reduce the expense in engineered whole-cell 
E. coli system. Engineered whole-cell S. cerevisiae could 
also synthesize endogenous sugar donors and produce 
heterogeneous proteins. These virtues motivated us to 
investigate the glycosylation of engineered yeast in vivo.
To data, all most of GTs (e.g. UDP-glucose: antho-
cyanin 3-O-glucosyltransferase) reported are involved 
in the biosynthesis of anthocyanin, however, only a few 
studies have reported the isolation and characteriza-
tion of GTs with strictly regio-selective glycosylation of 
flavonoid 7-hydroxyl group [23–29]. In this study, three 
additional flavonoid 7-O-glucosyltransferase genes from 
S. baicalensis were cloned and successfully expressed in 
E. coli. These three genes had high identities with the 
genes of the reported GTs from Scutellaria Species (Labi-
atae) (GenBank: AB031274, GU339042) [14, 24]. The 
results of the biochemical studies of SbGTs showed that 
the three SbGTs could regio-selectively catalyze scutel-
larein to scutellarein 7-O-glucoside, and only UDP-Glu 
could be used as a sugar donor. Additionally, SbGT34 
had the greatest affinity towards scutellarein (Fig. 1). The 
amino acid sequence of the three SbGTs shared very high 
identities (more than 90  %) to the reported UBGT and 
SbUGT [14, 24], but SbGT34 showed the greatest cata-
lytic efficiency for scutellarein compared with that of the 
SbGT56, which is most likely the counterpart of UBGT. 
Based on the alignment of their amino acid sequences 
and the homology modeling (data not shown), a signifi-
cant deletion of seven amino acid residues in SbGT30 
and SbGT34 was within the calculated loop region 
between the N- and C-terminal domains with similar 
Rossmann-like GT-B folds among the plant flavonoid 
GTs (Additional file 1: Figure S5). Additionally, there are 
several different amino acid residues between SbGT30 
and SbGT34 highlighted (Additional file 1: Figure S5), of 
which the function of these amino acid residues need to 
be further tested in detail.
The biocatalytic production of flavonoid glucosides 
using yeast as a biocatalyst is impaired by the metabolic 
activity of yeast glucosidases, which hydrolyze the gluco-
sidic bond between aglycone and glucosyl. A GT cloned 
from D. caryophyllus that could glucosylate naringenin 
to naringenin 7-O-glucoside was expressed in whole-
cell S. cerevisiae. However, the endogenous glucosidases 
reversely hydrolyzed naringenin 7-O-glucoside during 
whole-cell biocatalysis, resulting in a low final glucoside 
titre [16]. Sabine Schmidt et  al. had identified the three 
yeast β-glucosidases in yeast: EXG1, SPR1 and YIR007W, 
which played significant roles in the hydrolysis of flavo-
noid glucosides [17]. In this work, these three glucosi-
dase genes were disrupted in the engineered yeast. The 
EXG1 gene was identified in vivo as the decisive gene for 
the degradation of flavonoid glucosides. Strains with the 
deletion of the EXG1 gene did not hydrolyze the flavo-
noid glucosides (Fig. 2b), and the growth rate of the strain 
with the deletion of the SPR1 gene was greater than the 
wild strain and other recombinant strains (Fig.  2a). The 
SPR1 gene encodes a sporulation-specific glucanase and 
is transcribed only during the late stages of sporulation 
[30]. Deletion of the SPR1 gene contributes to change 
the proceeding of sporulation and promotes cell growth. 
The high growth rate of the strain with the deletion SPR1 
gene could shorten the process of fermentation. The con-
version rate of flavonoid in strain W303-1b/ES∆/SbGT34 
increased twofold compared with the rate in strain 
W303-1b/SbGT34 (Fig. 3). Therefore, the strain with the 
disruption of the EXG1 and SPR1 genes is proposed as an 
option to develop a platform for the expression of GTs 
and for the production of flavonoid glucosides in yeast 
transformants.
The combined strategy of deletion of glucosidases and 
the introduction of GTs plays pivotal roles in generating 
flavonoid glucosides. Plant GTs expressed in E. coli have 
been reported for the glycosylation of flavonoids [13, 22]. 
Based on the expression of the GTs in E. coli, the titre of 
the flavonoid glucosides was less than 100  mg/L in the 
culture broth [25, 26]. The two main factors for the bio-
synthesis of the desired products might be related to the 
availability of intracellular UDP-sugars and low activity 
of the GTs. Recently, a number of studies have primar-
ily focused on enhancing endogenous UDP-sugars by 
over-expressing genes that are part of the biosynthetic 
pathway of UDP-sugars and on exploring efficient GTs 
[22, 31–33]. In this study, the successful deletion of glu-
cosidases and the expression of the S. baicalensis fla-
vonoid GT in the engineered yeast for the whole-cell 
biocatalysis facilitated the bioconversion of aglycones 
and significantly improved the production of scutellarein 
7-O-glucoside. The scale-up feasibility of in  vivo glyco-
sylation has been applied for the large-scale production 
of scutellarein 7-O-glucoside by optimizing the appropri-
ate fermentation conditions. Consequently, up to 1.2 g/L 
of scutellarein 7-O-glucoside was produced after 54 h of 
fermentation (Fig. 7). As the titre of the desired products 
was remarkably high, the engineered strain W303-1b/
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ES∆/PU/SbGT34 is the most efficient strain for the pro-
duction of flavonoid glucosides in yeast ever reported.
Conclusions
The combined strategy of the deletion of endogenous 
glucosidases and the introduction of heterogenous GTs 
along with the up-regulation of biosynthetic pathway of 
UDP-Glu presents higher efficiency of the production of 
flavonoid glucosides. Through replacing other GTs and 
the regulating of biosynthetic pathway of UDP-sugars, it 
is applicable to extend the regio-specific glycosylation to 
more secondary metabolites as pharmaceutical ingredi-
ents for future clinical application.
Methods
Strains
Escherichia coli DH5α (TransGen, Beijing, China) was 
used for propagation and manipulation of the recom-
binant DNA, and E. coli BL21 (DE3) was employed for 
expression of the recombinant enzymes. S. cerevisiae 
W303-1b (MATα ade2-1 leu2-3, 112 his3-11, 15 ura3-1 
trp1-1) was used for construction of engineering strain 
as a whole-cell biocatalyst for production of flavonoid 
glucosides. E. coli strains were cultured at 37  °C in LB 
medium (5 g/L yeast extract, 10 g/L tryptone and 10 g/L 
NaCl), and yeast transformants were grown at 30  °C in 
YPD medium (10 g/L yeast extract, 20 g/L tryptone and 
20 g/L glucose).
Expression and purification of recombinant SbGTs
To prepare the recombinant SbGT enzymes, the veri-
fied cDNA clones corresponding to SbGT30, SbGT34 
and SbGT56 were amplified, digested with restriction 
enzymes Nco I and BamH I, and then ligated into the 
same sites of the expression vector pTWIN1B, a deriv-
ative of the plasmid pTWIN1 (NEB, Biolabs) (Addi-
tional file  1). After the verification of the sequences, 
the resulting pTWIN1B-SbGTs plasmids and a control 
pTWIN1B were transformed into E. coli BL21 (DE3) for 
heterologous expression. Luria–Bertani (LB) medium 
(10 mL) containing 100 μg/mL of ampicillin was inocu-
lated with 1  mL of an overnight culture corresponding 
to each selected genes and a control vector. Cells were 
grown at 37  °C with shaking (200 rpm) until the OD600 
achieved 0.4–0.6. The recombinant N-terminal CBD-
tagged SbGTs were induced with 130  μg/ml isopropy 
β-D-thiogalactoside (IPTG) for 20 h at 16 °C with shak-
ing (165  rpm). Cells were harvested by centrifugation 
at 8000  g for 5  min at 4  °C. Pellets were resuspended 
in 100  mL of chilled binding buffer (20  mM HEPES, 
500 mM NaCl, NaOH solution was added until pH was 
8.5). Cells were disrupted with 800  bar high pressure 
using high pressure homogenizer and the cell debris 
was removed by centrifugation at 10,000 g and 4  °C for 
30 min.
The cleared supernatant was immediately applied to 
10 mL of chitin resin (NEB, Biolabs) loaded in a column 
that was pre-equilibrated with binding buffer. The chi-
tin resin was subsequently washed with 100  mL of the 
washing buffer (20 mM HEPES, 500 mM NaCl, pH 8.5). 
Then, the washing buffer was replaced by the cleavage 
buffer (20  mM HEPES, 50  mM NaCl, pH 6.5) and the 
recombinant protein was cleaved at 4 °C for 3 days. Elu-
tion was carried out with 25  mL of the cleavage buffer, 
and the recombinant protein was desalted in 10-times 
diluted cleavage buffer and was then lyophilized. Protein 
purity was confirmed by SDS-PAGE to be >90 % (Addi-
tional file 1: Figure S1), and the protein concentration for 
all studies was determined by the protein quantitative kit 
(Bradford) (Bio-Rad, USA).
Glycosyltransferase activity assays in vitro
Three SbGT genes, SbGT30, SbGT34 and SbGT56, were 
identified and heterologously expressed in E. coli. The 
donor specificity of these recombinant proteins was 
analyzed using scutellarein as a glucosyl acceptor and 
UDP-Glu, UDP-GA and UDP-Gal as sugar donors. The 
reaction mixture (200 μL) for the GTs contained 50 mM 
citrate buffer (pH 6.5), 0.6  mM UDP-Glu, 0.2  mM sub-
strate dissolved in dimethylsulfoxide (DMSO) and 10 μg 
of the purified SbGTs. Activity assays, which were initi-
ated through the addition of enzymes, were incubated at 
30 °C for 30 min and were terminated by adding 200 mL 
of methanol. The reaction mixture was subjected to 
HPLC analysis for the detection of the reaction product.
Effects of pH, temperature and divalent metal ions 
on enzyme activity
To test the necessity of divalent metal ions for SbGT34, 
CaCl2, CoCl2, CuCl2, MgCl2, FeCl2, MnCl2, ZnCl2 and 
EDTA were used individually at a final concentration of 
5 mM. To study the optimal pH, the enzymatic reaction 
was performed in various reaction buffers with pH val-
ues in the range of 4.0–6.5 (citrate buffer), 6.0–8.0 (phos-
phate buffer) and 7.5–9.0 (Tris–HCl buffer). To assay for 
the optimal reaction temperature, the reaction mixtures 
were incubated at different temperatures (0–70 °C). The 
assays were performed with UDP-Glu as a donor and 
scutellarein as an acceptor.
Determination of kinetic parameters
Assays were performed in a final volume of 200 μL con-
sisting of 50  mM Tris–HCl (pH 7.5) at 30  °C, and con-
tained constant concentrations of enzyme (10  μg) and 
saturating UDP-Glu (2  mM) while varying the scutel-
larein concentration (0.1–1.0  mM). Reactions were 
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terminated at 10 min (where the rate of product forma-
tion was determined to be linear) by adding an equal 
volume of ice cold methanol. Mixtures were filtered and 
analyzed using reverse-phase HPLC, and the total per 
cent conversion was calculated as the per cent of the total 
peak area of the substrate and product. All experiments 
were performed in triplicate. The value of Km was calcu-
lated using a Lineweaver–Burk plot.
Construction of yeast expression plasmids and yeast 
transformation
All strains and plasmids used in this study are listed in 
Table 1. The plasmid construction and yeast transforma-
tion methods were same as in [34]. All plasmids were 
constructed using conventional restriction enzyme-
mediated cloning methods. Based on the nucleotide 
sequences of the target genes, development of primer 
sets were designed and used to amplify gene fragments 
by PCR (Additional file  1: Tables S1–S6). The δ DNA-
mediated integrative expression vector was used for the 
cloning of the polymerase chain reaction (PCR) products 
and the expression of the genes [35]. The acquired plas-
mids were linearized by digestion with the restriction 
enzyme Not I or Hind III and were transformed into the 
S. cerevisiae using the lithium acetate method. Transfor-
mants were selected using yeast extract peptone dextrose 
(YPD) agar plates containing the antibiotics Geneticin 
(G418, 4  mg/mL) or Hygromycin B (HygB, 1  mg/mL), 
and the double homologous recombination of the target 
genes was verified by PCR using the corresponding prim-
ers and Sanger sequencing using the isolated genomic 
DNA as a template. The repeated introduction of the 
marker genes was implemented via a loxP-marker-loxP 
gene disruption cassette [36].
Deletion of glucosidases in S. cerevisiae
In S. cerevisiae, glucosidases EXG1, SPR1 and YIR007W 
have previously been identified as the three yeast 
β-glucosidases previously [17]. To disrupt these glucosi-
dase genes, three homologous integration vectors were 
constructed (Additional file  1: Methods). Then, 5  μg of 
the resulting plasmids that were linearized by the diges-
tion with restriction enzyme Not I or Hind III were 
transformed into S. cerevisiae using the lithium acetate 
method. Transformants were identified on synthetic 
selective medium agar plates without tryptophan (for 
gene EXG1), adenine (for gene SPR1) or uracil (for gene 
YIR007W), respectively [37]. The double homologous 
Table 1 Strains and plasmids used in this study
Strains or plasmids Relevant properties Source or reference
Strains
 E. coli trans1-T1 F− φ80(lacZ)∆M15 ∆lacX74 hsdR(rK− mK+)∆recA1398 endA1 tonA Our lab
 E. coli BL21 (DE3) F− ompT hsdS (rBB-mB−) gal dcm Our lab
 S. cerevisiae W303-1b MATα ade2-1 leu2-3, 112 his3-11, 15 ura3-1 trp1-1 Our lab
 W303-1b/EXG1∆ W303-1b derivative with pEZ-EXG36-Trp1, EXG1∆::Trp1 This study
 W303-1b/SPR1∆ W303-1b derivative with pEZ-SPR36-ADE2, SPR1∆::Ade2 This study
 W303-1b/YIR007W∆ W303-1b derivative with pEZ-YIR36-Ura3, YIR007W∆::Ura3 This study
 W303-1b/ES∆ W303-1b derivative with pEZ-EXG36-Trp1 and pEZ-SPR36-ADE2, EXG1∆::Trp1, SPR1∆::Ade2 This study
 W303-1b/SbGT34 W303-1b derivative with pδGAPg-SbGT34 This study
 W303-1b/ES∆/SbGT34 W303-1b/ES∆ derivative with pδGAPg-SbGT34 This study
 W303-1b/ES∆/PU/SbGT34 W303-1b/ES∆ derivative with pδGAPg-PGM2, pδGAPh-UGP1, and pδGAPg-SbGT34 This study
Plasmids
 pTWIN1B A derivative of pTWIN1, an inducible expression vector with ampicillin resistant. Our lab
 pTWIN1B-SbGT30 pTWIN1B derivative with the SbGT30 gene DNA This study
 pTWIN1B-SbGT34 pTWIN1B derivative with the SbGT34 gene DNA This study
 pTWIN1B-SbGT56 pTWIN1B derivative with the SbGT56 gene DNA This study
 pEZ-EXG36-TRP1 Integration vector with Homologous fragment of EXG1 and selective marker TRP1 This study
 pEZ-SPR36-ADE2 Integration vector with Homologous fragment of SPR1 and selective marker ADE2 This study
 pEZ-YIR36-URA3 Integration vector with Homologous fragment of YIR007W and selective marker URA3 This study
 pδGAPg pBluescript II KS(+) derivative with homologous δ region, Pgap, Tpgk1, G418r [34]
 pδGAPh pBluescript II KS(+) derivative with homologous δ region, Pgap, Tpgk1, HygBr [34]
 pδGAPg-PGM pδGAPg derivative with PGM2 from S. cerevisiae, G418r This study
 pδGAPh-UGP1 pδGAPh derivative with UGP1 from S. cerevisiae, HygBr This study
 pδGAPg-SbGT34 pδGAPg derivative with SbGT34 from S. baicalensis, G418r This study
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recombination of the glycosidase locus was verified by 
PCR using the corresponding primers and the corre-
sponding genomic DNA as a template. The amplified 
DNA fragments of the positive constructs were further 
verified by DNA sequencing (Taihe, Beijing, China).
Analysis of the glucosidase activity in the knockout strains
After each successful deletion, strains W303-1b, 
W303-1b/EXG1∆, W303-1b/SPR1∆ and W303-1b/
YIR007W∆ were grown at 30  °C in YPD medium for 
24 h, and the culture was then inoculated into fresh SC 
medium (2  % w/v glucose, 0.67  % w/v yeast nitrogen 
base without amino acids and 2 g/L complete amino acid 
mixture) at 1  %, and the cells were grown at 30  °C for 
approximately 10 h. The initial OD600 of the yeast seeds 
in the SC media was adjusted to 1.0 and 0.2 mM luteolin 
7-O-glucoside was then added to the medium. The 1 mL 
reaction mixture in 5-mL reaction flasks was incubated at 
30 °C for 10, 30 min, 1, 3, 6, 12 and 24 h. After the com-
pletion of the reaction, the reaction products of three 
independent experiments were lyophilized and extracted 
using 500  μL of methanol three times. The combined 
extracts were evaporated and then re-dissolved in 1 mL 
of methanol. The hydrolytic rate of each strain for luteo-
lin 7-O-glucoside was determined using HPLC analysis.
Analysis of the dynamic effects of glucosidase activity 
on the production of the desired glucosides
To further confirm whether the strains harbouring 
SbGT34 with or without the deletion of glucosidase 
genes had different substrate conversion rates, strains 
W303-1b/SbGT34 and W303-1b/ES∆/SbGT34 were 
selected to explore the remaining glucosidase activity. 
Strains W303-1b/SbGT34 and W303-1b/ES∆/SbGT34 
were grown at 30  °C in YPD medium for 24  h, and the 
culture was then inoculated into fresh SC medium at 
1 % and the cells were grown at 30 °C for approximately 
10 h. The initial OD600 of the yeast seed in the SC media 
was adjusted to 1.0 and 0.2  mM scutellarein was then 
added to the medium. The 1-mL reaction mixture was 
incubated at 30  °C for 3, 6, 12, 24, 48 and 72 h in 5-mL 
reaction flasks. After the completion of the reactions, the 
reaction products were processed as mentioned above. 
The conversion rate of each strain for scutellarein was 
determined using HPLC analysis.
Assay on S. cerevisiae whole‑cell biocatalyst
Integrative S. cerevisiae transformants were grown 
overnight at 30  °C in YPD medium until the OD600 was 
approximately 3.0 as a seed culture. One hundredth of 
the volume of the seed culture was inoculated into the 
SC medium and was grown at 30  °C for approximately 
10  h, and the OD600 was adjusted to 1.0 using fresh SC 
medium. Substrates were added to 1  mL of the regu-
lated cell suspension. All of the results shown in this 
paper were obtained from at least three independent 
experiments.
Yeast strain W303-1b/ES∆/PU/SbGT34 at the same 
cell density (initial OD600 1.0) was used for the substrate 
inhibition tests. Different concentrations of scutella-
rein (0.2, 0.4, 0.6, 0.8, 1.0 mM) dissolved in DMSO were 
used to biotransform in a 1-mL culture volume in 5-mL 
reaction flasks. Three independent experiments were 
removed from the shaker for each concentration and for 
each reaction time interval. The reaction solutions were 
lyophilized, and the samples were then extracted using 
500  μL methanol three times. The three methanol frac-
tions were merged and completely volatilized, and then 
re-suspended into 1  mL of methanol, and subjected to 
HPLC analysis. The final conversion of substrate was cal-
culated according to a standard curve of scutellarein and 
scutellarein 7-O-glucoside.
Glucose supplementation and pH optimization
The yeast strain W303-1b/ES∆/PU/SbGT34 was used for 
glucose supplementation and pH optimization in a bio-
transformation reaction. Firstly, four different concen-
trations of glucose (2, 5, 10, 15 %) were supplemented in 
the SC medium with 0.6 mM scutellarein as a substrate 
to determine the optimum concentration of glucose for 
biotransformation. Secondly, when the optimum con-
centration of glucose was determined, 50 mM phosphate 
buffer solution was added to the fermentation medium in 
four pH gradients (4.5, 5.0, 5.5, 6.0) to ascertain the opti-
mal pH for bioconversion. The original cell density and 
disposing methods of the samples were same as men-
tioned above. Finally, HPLC analysis was carried out, 
and the conversion rate of the substrate into product was 
determined.
Whole‑cell biocatalyst assay in the fermenter system
A 10-L glass autoclavable fermenter system (Beauty, 
Shanghai, China) was used for the large-scale analysis 
of the strains harbouring SbGT34 as a whole-cell bio-
catalyst. The strain W303-1b/ES∆/PU/SbGT34 that was 
cultured overnight (200  mL) was transferred into the 
fermenter system containing 4  L of SC medium, and 
the original OD600 was adjusted to 1.0. The culture was 
fed with 1.0  mM scutellarein (dissolved in DMSO) (at 
0 h) and 2.0 mM (at 12 h) as a substrate, and the incu-
bation temperature and dissolved O2 were 30  °C and 
25 %, respectively. The pH of the medium was regulated 
to remain at approximately 5.5 through the addition of 
a 12.5  % ammonia solution. Samples were harvested 
at 6  h intervals, and the growth of the cells was meas-
ured at 600 nm. The resulting solution fractions (culture 
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medium) were disposed as mentioned above and ana-
lysed using HPLC.
Product analysis and quantification
The culture extracts dissolved in methanol were directly 
performed on reverse-phase HPLC connected to a C18 
column (Mightysil RP-18 GP 4.6  ×  250  mm, 5  μm) 
at 280  nm using binary conditions of H2O (0.05  % trif-
luoroacetic acid, mobile phase A) and 100 % acetonitrile 
(ACN) (mobile phase B) at a flow rate of 1  ml/min for 
40  min. The analyses of the substrates and their prod-
ucts were conducted using the following gradient pro-
gram: 0–25  min (10–35  % B), 25–27  min (35–100  % 
B), 27–32  min (100  % B), 32–35  min (100–10  % B), 
35–40 min (10 % B). To quantify the flavonoid glucosides, 
a calibration curve of scutellarein 7-O-glucoside was 
created using 0.05, 0.1, 0.2, 0.5, 0.6, 0.8, 2.0 and 4.0 mM 
concentrations.
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